Keystone Nano, Inc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT04716452) | Keystone Nano, Inc | 2025-10-01 |
Track Keystone Nano, Inc automatically
Every clearance here is in the API, with alerts when new ones post.